作者使用泰国Mahidol大学制备的2型登革热减毒活疫苗(经多种细胞传代获得)在不同人种中进行了安全性和免疫原性评估.试验人群为7男3女.其中6名高加索人.2名黑人,2名西班牙裔美国人.对所有受试者在左臂三角肌区皮下注射1ml疫苗.在免疫后21天内.每天观察症状和体证,并在 The authors evaluated safety and immunogenicity in different ethnic groups using a live attenuated dengue type 2 vaccine prepared by the University of Mahidol, Thailand (passaged on numerous cell lines) in a study population of 7 males and 3 females, of whom 6 were Caucasians .2 blacks and 2 Hispanics.All subjects were injected subcutaneously with 1 ml of vaccine in the deltoid area of ​​the left arm and within 21 days after the immunization, symptoms and evidence of body were observed daily, and at